chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received injection at 12 pm, Chest pain and shortness of breath started 6 hrs after shot (6 pm). At 8 PM, horrible chills started, lasting three hours, nothing could warm me up, wore multiple warm layers and three blankets, lasting 3 hrs.  Was able to get to sleep with no problems, slept through the night.  When waking in the morning, terrible joint pain and muscle aches over entire body, especially flared up my chronic low back pain. Nausea during the first half of the day wouldn't allow me to eat anything. Slight tightness in chest during the day, and pain over entire body lasted until the late afternoon. This pain over my entire body through the day is the worst I have ever been sick, in my lifetime.
- a lot of oil-like fluid coming out of right nipple of the breast  - clear liquid with no smell  - no pain  - happened the same day as vaccination, but a few hours after given the shot
Expired dose administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered). On 26-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Immediately after patient was injected with FLUVIRIN (flu vaccine) the patient developed an anaphylactic reaction requiring an EPI PEN injection on site and care at the local hospital. After the injection was given the patient complained of dizziness, tingling fingers, tachycardia, warm and hard injection site, and difficulty breathing. One EPIPEN was administered and an ambulance arrived 5 minutes after they were called.
Screaming, red at immunization site. Right, bright red size of nickel. Temperature 101. Screaming/unconsolable for 8-10 hours.
Cough, abdominal pain, pneumonia, shortness of breath, multiple subsegmental pulmonary embolism, Lovenox shots, warfarin, antibiotics, nebulizer treatments, albuterol.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 48-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 21Sep2023 at 10:00 as dose 1, single (Batch/Lot number: unknown) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Menopause" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, latency 10 days after the suspect product(s) administration, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from 05Oct2023 to 09Oct2023.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: The efficacy of a vaccine varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine product to the reported events drug ineffective and COVID-19 cannot be ruled out.
Mom called on 6/5/15 as patient had syncopal episode at school. Recovered quickly but school staff mentioned syncopal episode could be due to Hepatitis A injection. Advised parents to take her to ED for evaluation.
Eight hours after receiving the shot, I experienced severe chills, headache, nausea, and dizziness. This subsided by 2PM the following day. However, within a few hours after it subsided, I experienced nausea, dizziness, heaviness in the back of my head and intermittent headaches on and off for the next 3 weeks. The severity is diminishing, but it has not gone completely away.
Breakthrough case admission after three vaccines pfizer 1/27/21 Lot# EL9264;  Pfizer 2/17/21 Lot# EN6200;  Pfizer 10/5/21 Lot# FC3181
Child described difficulty swallowing. Gave 25mg BENADRYL - shortly after child states he feels fine. Observation for 45min.
Vaccines given at approximately noon.  After lunch, reaction started with nausea, chills, light-headed, vomited x1, hyperventilating.  Seen in EC and treated with IV fluids and Benadryl 50 mg IV.  Discharged at 1730.
Redness/swelling o n(L) thigh - 1 day after receiving Flu vaccine.
This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (minor soreness in arm) and HEADACHE (mild headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K202A) for COVID-19 vaccination.     The patient's past medical history included Migraine (Stress migraines).    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (minor soreness in arm) and HEADACHE (mild headache). At the time of the report, VACCINATION SITE PAIN (minor soreness in arm) and HEADACHE (mild headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was a runner and was naïve to medications. Patient states he has no allergies, medical history, except stress migraines. Treatment product was not provided by the reporter.  Company Comment The events were downgraded to non serious due to being related to the first dose of the vaccine.   This case was linked to MOD-2021-388577 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jan-2022: Significant follow up. Reporter details was updated, patient history updated and lot/batch number was added. Sender's Comments: The events were downgraded to non serious due to being related to the first dose of the vaccine.
Very tired; This is a spontaneous report received from a non-contactable reporter (Consumer). The reporter is the patient.  A 49 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 18Mar2021 17:00 (Lot number: ER2613) at the age of 49 years as dose 1, single for covid-19 immunization. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: Asthma (moderate); "Post-traumatic stress disorder" (unspecified if ongoing), notes: PTSD; "Fibromyalgia" (unspecified if ongoing); "Sulfonamide allergy" (unspecified if ongoing), notes: known allergies: Sulfa. Concomitant medications included: ZOLOFT; DULERA; FLONASE [FLUTICASONE PROPIONATE]; ALLEGRA; SINGULAIR. Past drug history included: Vicodin, reactions: "Drug allergy", notes: known allergies: Vicodin; Dilaudid, reactions: "Drug allergy", notes: known allergies: Dilaudid. The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "Very tired".  Additional information: On an unknown date in 2021, after the first vaccination on 18Mar2021, the patient was very tired. The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.   No follow-up attempts are possible. No further information is expected.
Minutes after receiving GARDASIL 9 the patient followed her mother into the inner waiting room, area to receive a copy of her shot record. Without warning, she fell backwards hitting her head & losing consciousness. She was immediately placed in Trendelenburg became conscious pt 45-60 sec she remained pale c/o H/A and dizziness. Nystagmus noted. After 15 min she remained pale and not improving. ER strongly recommended. Follow up call to mom on 8-13-15 confirmed a skull fracture on CAT scan.
I obtained the first dose of the Covid 19 Pfizer vaccine on Saturday  August 28 2021 after discovering that I was pregnant the same day.  My blood test was drawn to check my HCG levels on Tuesday August 31st 2021 and Thursday September 2nd 2021 and results showed that pregnancy was progressing normally based on the levels obtained these two days. On Saturday September 4th 2021 I started to bleed (light bleeding, spotting). It happened in the morning  then stopped a bit and it happened again in the afternoon. I experienced light bleeding and spotting again on Sunday September 5th 2021. On Monday September 6th I continued to experience light bleeding during the day but the the flow of blood increased at night.  I contacted my doctor on Monday September 6th she advised me to get another blood test to check my HCG level on Wednesday September 8th 2021. On Tuesday September 7th  the bleeding became heavy like a period. I continued to bleed heavily on Wednesday September 8th 2021. I got my blood test done on Wednesday September 8th 2021 per my doctor's instruction. Today Thursday September 9th 2021 I got my results back and my HCG level dropped to non pregnant level.  I spoke with my doctor's nurse today Thursday September 9th and after she reviewed the HCG number she informed me that I had suffered a miscarriage.  I am still experiencing bleeding today Thursday September 9th 2021.
I received my first Pfizer booster for COVID-19 on 11/23/21. On the morning of 11/13/2022, I didn't feel well. I felt like I was getting a cold, because I had fatigue. I then later developed a fever, felt hot, and had a slight headache. I took a home antigen test on 11/14/2022 and got a positive result. I contacted my doctor, who prescribed me Paxlovid, which I started taking the morning of 11/15/2022. Along with the abovementioned symptoms, I have had a dry cough, occasional runny nose, and night sweats. Ever since the night of 11/21/2022, I have had night sweats. The sweats were really bad on the nights of 11/21/2022 and 11/22/2022, but they are now less severe. I hope they have finished coming. I have also started coughing more frequently after finishing Paxlovid, though it is still a dry cough. During the time I was taking the Paxlovid, I had a bitter taste in my mouth that was kind of like the aftertaste from eating a grapefruit, but once I finished the medication, the aftertaste went away. Per my doctor's orders, ever since I tested positive on 11/14/2022, I have been taking vitamins D and C and zinc. I took a home antigen test on 11/23/2022 and got a negative result.
Patient complains of redness and pain at injection site.  The pain was reported to be gone after a week with the redness decreasing in size one week after injection.
Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients; No adverse event; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     Patient did not report any medical history, conditions, allergy, concomitant diseases, or risk factor (including any previous COVID-19 diagnosis). It was reported that patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients).    Concomitant drugs were not reported. It was reported that vaccines were administered to 20 patients between 13-Mar-2023 to 05-Jun-2023 past the BUD of 17-Feb-2023. Patients received the vaccine either as the 3rd, 4th or 5th dose. Treatment medications were not provided.  This case was reported for patient 11 of 20.
High fever 106.8; lethargic; zoned out. Fever would come and go for months and months.
Initial symptoms were mild, sporadic, and infrequent (i.e. tingling in my feet only when I biked). Symtoms were limited to my feet and then over a month's time migrated to include tingling in my hands, and eventually to tingling throughout my body, and now, two months after the vaccine, I have full body nerve pain and began taking Neurontin. I have not officially been diagnosed with MS, but the symptoms are classic to MS.
Body including legs are achy; Body including legs are achy; This case was reported by a consumer and described the occurrence of general body pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 26th February 2021, the patient received the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced general body pain and leg pain. On an unknown date, the outcome of the general body pain and leg pain were not recovered/not resolved.   It was unknown if the reporter considered the general body pain and leg pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the second dose of Shingrix and then her body including legs were achy. No additional information was provided. The reporter did not consent to follow-up and did not wanted to provide address, date of birth or any additional information.
Information has been received from a physician's assistant concerning a 17 year old female who on 21-MAR-2007 was vaccinated with the first dose of Gardasil. On 04-APR-2007 the patient was diagnosed with genital warts. unspecified medical attention was sought. At the time of this report, the patient's genital warts persisted. Additional information has been requested.
When performing the vaccine count it was noted there was 1 more vial of the live virus vial than the diluent syringe.  Three patients have received doses so it is unclear if this patient received the correct dose.
Numbness in face, nervousness, ringing in ears. Very emotional later had tremors jerking movements called ambulance.
19 DAYS AFTER  RECEIVING VACCINE VERTIGO WITH NAUSEA - TREATED IN ER ON 2/19/21
Father called to report patient experienced rash over lower and upper limbs and abdomen.  Generalized body rash.  Did not report any medical action taken at time of conversation.  Reports rash first noticed evening after receiving vaccine.  Recommended follow up with primary care physician.
Metallic taste, face swelling, redness and itching.  Chest tightness.
On 12/20/02 got DTap, mom stated she got a knot the size of her hand on that site.  Child was taken to Urgent Care.
Pain at injection site, headache, fever, fatigue, extreme pain all over body  , skin is painful to the touch, nauseous, dizzy and difficulty walking, extreme perspiration while sleeping
Patient was provided a dose of Engerix B vaccine to soon after last dose was given. Patient denies any vaccines in last 4 weeks.
numbness, burning and tingling in hands; Burning and tingling in hand; tingling in hand; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness, burning and tingling in hands), BURNING SENSATION (Burning and tingling in hand) and PARAESTHESIA (tingling in hand) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness, burning and tingling in hands), BURNING SENSATION (Burning and tingling in hand) and PARAESTHESIA (tingling in hand). The patient was treated with GABAPENTIN for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (numbness, burning and tingling in hands), BURNING SENSATION (Burning and tingling in hand) and PARAESTHESIA (tingling in hand) outcome was unknown.            No concomitant drugs were reported. treatment drug reported were muscle relaxants.
Eye exposure to the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT. At the time of the report, ACCIDENTAL EXPOSURE TO PRODUCT outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment was not reported/ unknown.  This report refers to a case of expired product administered for mRNA-1273 with no associated AEs.   Reporter did not allow further contact. Sender's Comments: This report refers to a case of expired product administered for mRNA-1273 with no associated AEs.
Seen at urgent Care( Physician exam note): GENERAL: alert, interactive, non toxic appearing, no respiratory distress, well hydrated: HEENT: no nasal discharge, MMM, throat clear with no significant tonsillar erythema, enlargement, or exudates, PERRLA EOMI; NECK: supple, non tender, no meningismus: LUNGS: clear to auscultation, no wheezes or prolonged expiratory phase, no rales, no retractions, breath sounds equal bilaterally with good air entry: HEART: RRR, no murmurs, rubs, or gallops: ABD: soft, non tender, no rebound or guarding, bowel sounds present, no CVA tenderness: EXTREM: L deltoid area with 6x8cm area of redness/swelling/induration c/w cellulitis, no fluctuance or drainage, n/v of hand intact: SKIN: no rashes: NEURO: alert, normal mental status, grossly normal motor and sensory exams: Discharge Instructions: Clindamycin and warm compresses as directed.  Please seek medical care/go to ER for fever, pus from area, worsening redness/swelling, other worsening. We appreciate being able to provide excellent service to you.  We hope your child feels better soon.
Admitted with weakness,Diagnosed at admission with COVID-19,O2 at ome time, but was weaned off. unable to do chemical DVT prophylaxis due to anemia and possible GI bleed.  No remdesivir due to ESLD. Given steroids - will complete 10 day. D/c to home onsteriods, Home health refferal.
Diagnosed with Extreme Vertigo, when she sat on the toilet the room started spinning, when she turned to the left while lying in the bed, the room started spinning; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Diagnosed with Extreme Vertigo, when she sat on the toilet the room started spinning, when she turned to the left while lying in the bed, the room started spinning) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Aug-2021, the patient experienced VERTIGO (Diagnosed with Extreme Vertigo, when she sat on the toilet the room started spinning, when she turned to the left while lying in the bed, the room started spinning) (seriousness criterion disability). The patient was treated with MECLIZINE HCL for Vertigo, at a dose of 12.5 mg. At the time of the report, VERTIGO (Diagnosed with Extreme Vertigo, when she sat on the toilet the room started spinning, when she turned to the left while lying in the bed, the room started spinning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not provided.  Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded. Neither medical history, nor concomitant medication were provided. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded. Neither medical history, nor concomitant medication were provided. Further information has been requested.
Sharp headache upon waking on second day (about 36 hours after injection). Required Aleve over the counter, which did alleviate the symptoms after an hour.
VARICELLA AND FLU VACCINE GIVEN ON 10/22/07 LEFT ARM.  PATIENT RETURN TO CLINIC ON 10/24/2007.  HE SAW DR.  PRESENTED WITH LEFT ARM SWOLLEN AND RED FROM ELBOW TO SHOULDER AND WARM TO TOUCH.  PER DR. BENADRYL WAS ADMINITERED PO 25 MG.
Left leg very swollen area 48 hours with rash in pink mottled by 3 by 6 inches. Minimally tender, low grade temp.
Information has been received from a registered nurse concerning a "late teens" female who, "about 4 months ago," in approximately December 2006, was vaccinated with her first dose of Gardasil (dose and date not reported). Subsequently the patient fainted about six hours after receiving her first dose. Patient reported experience when in office for second dose. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 4/13/2007. Information has been received from a licensed practical nurse concerning a 15 year old female with an allergy to KEFLEX who on 27-JUL-2006 and 23-OCT-2006 was vaccinated IM with her first and second 0.5 ml dose of GARDASIL (lot# 653937/0637F). It was reported that the patient came in for her third dose and she told the nurse that she had passed out a couple hours after her second vaccination (recovered same day 23-OCT-2006). She was advised per her physician's office that she could not be administered the vaccine without a parent available to drive her home. The patient came back in with her mother. The patient's mother was advised that this reaction could be worse than the second reaction and could possible require medical attention. The patient was vaccinated IM with her third 0.5 ml dose on 14-FEB-2007. The patient's mother agreed to monitor her that evening. Additional information is not expected.